Palmitic acid in cancer research: mechanistic insights from in vitro and in vivo studies.

Authors

Muhammad Muzammil Nazir, Sehrish Muzaffar, Saima Muzammil, Asma Ashraf

Published in

Naunyn-Schmiedeberg's archives of pharmacology. Jun 19, 2026. Epub Jun 19, 2026.

Abstract

Palmitic acid (PA), a long-chain saturated fatty acid abundantly present in dietary lipids and endogenous metabolic pathways, has traditionally been associated with metabolic dysregulation. However, emerging experimental evidence has revealed a contrasting role for PA in cancer biology. This review critically summarizes recent in vitro and in vivo studies investigating the anticancer potential of PA across multiple malignancies, including gastric, breast, colorectal, prostate, and endometrial cancers. Accumulating data demonstrate that PA suppresses tumor cell proliferation, induces apoptosis and autophagy, and inhibits invasion and metastasis through modulation of key molecular pathways such as STAT3, PI3K/Akt, ER stress signaling, and cell cycle regulators. In addition, PA-based delivery systems and combination strategies have shown enhanced antitumor efficacy by promoting macrophage repolarization and improving chemotherapeutic outcomes. Despite these findings, the anticancer effects of PA appear to be highly context-dependent, influenced by concentration, exposure duration, and tumor type. Collectively, this review highlights the mechanistic basis and therapeutic relevance of PA in cancer models while emphasizing the need for careful interpretation and further validation before clinical translation.

PMID:
42319420
Bibliographic data and abstract were imported from PubMed on 19 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.